Movement Alert|Albemarle Rises 6.36% in Regular Trading, Multiple Institutions Maintain Buy Ratings with Targets Well Above Current Price

Market Focus06-30

On June 30, Albemarle rose 6.36% in regular trading, trading at approximately $136.52/share, with turnover of $30.77 million. The rebound comes after the stock plunged over 15% from approximately $157 to $134 in the prior week amid broad lithium sector weakness.

On the news front, Jefferies adjusted its target price on Albemarle from $244 to $211 while maintaining a Buy rating, implying roughly 55% upside from current levels. According to FactSet, the analyst consensus target price stands at $218.37, with Citi, RBC, UBS, and other major institutions maintaining buy or outperform ratings, with targets concentrated in the $211 to $264 range — all significantly above the current stock price. The sharp prior-week selloff and sustained institutional bullishness suggest the current move carries characteristics of an oversold technical recovery.

Within the Specialty Chemicals sector, Sociedad Quimica Y Minera De Chile SA up 4.45%, Element Solutions up 1.45%, Balchem up 0.41%, Ecolab up 0.27%, Sherwin-Williams down 0.83%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment